Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 10, 2023

BUY
$1.68 - $2.84 $17,525 - $29,626
10,432 Added 86.93%
22,432 $56,000
Q1 2023

Apr 04, 2023

BUY
$1.21 - $2.86 $14,520 - $34,320
12,000 New
12,000 $23,000

Others Institutions Holding GLTO

# of Institutions
1
Shares Held
21.2K
Call Options Held
0
Put Options Held
0

About Galecto, Inc.


  • Ticker GLTO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,395,700
  • Market Cap $119M
  • Description
  • Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB2064, which is in Phase IIa for the treatment of myelofibrosis. It also develops GB0139, an inhaled inhibitor of galectin-3 that is in Phase IIb clini...
More about GLTO
Track This Portfolio

Track Trust CO Of Toledo Na Portfolio

Follow Trust CO Of Toledo Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trust CO Of Toledo Na , based on Form 13F filings with the SEC.

News

Stay updated on Trust CO Of Toledo Na with notifications on news.